Abstract
One of the dominant features of the regulation of modern health systems is the way in which technological and medicinal innovations are introduced and monitored. Canada is not immune to the complexity of this systems, which this article tries to clarify by presenting the case of the province of Quebec where, in 2011, the National Institute for Clinical Excellence in Health and Social Services (INESSS) was established. In the regulation of the Quebec health system context, INESSS contributes to regulation by assessing the added value of innovations in order to optimize their health and economic benefits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
